| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 8.9 | 11.8 | 11.1 |
| Other income | 1.6 | 1.5 | 1.5 |
| Total income | 10.5 | 13.3 | 12.6 |
| Profit before exceptional items & tax | -1.0 | 2.9 | 3.2 |
| Exceptional items | 0.1 | -0.3 | -0.0 |
| Profit before tax | -0.9 | 2.6 | 3.2 |
| Net profit | -3.2 | 1.9 | 1.2 |
| Operating margin | -8.6% | 19.5% | 25.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | -19.80% |
|---|
Source
Read the filing ↗
BSE results filing, NSE: ZENOTECH. Figures extracted from the filing.
Zenotech Laboratories Ltd: key numbers
- Share price
- ₹42.15
- Market cap
- ₹257.2 Cr
- Revenue (annual)
- ₹43.61 Cr
- Net profit (annual)
- ₹-1.07 Cr
- P/E (TTM)
- -102.2×Sector 50.4×
- Promoter holding
- 68.84%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zenotech Laboratories Ltd
All →
15:25 IST
BSE
Annual General Meeting
Zenotech Laboratories Annual General Meeting
Zenotech Laboratories Limited concluded its 37th Annual General Meeting. Shareholders approved the adoption of financial statements and re-appointment of Mr. Jignesh Anantray Goradia as Director.
14:41 IST
BSE
Financial Results
Zenotech Laboratories Q1 FY27 Results: Net Loss of ₹0.5 Cr
Zenotech Laboratories Ltd reported revenue from operations of ₹9.6 Cr (+11.6% YoY) and a net loss of ₹0.5 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.5 Cr